Federal Trade Commission approves $21.4 billion takeover of General Electric’s biopharmaceutical business after Danaher agreed to sell assets to Sartorius AG.
- Danaher will divest assets related to 10 products used to manufacture biopharmaceutical drugs, FTC says
- NOTE: Companies won EU antitrust
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.